SCHEMBL21390052

SCHEMBL21390052

O=C1COC2CCN(C(=O)N3CC(c4ccc(N5CC(OCC(F)(F)F)C5)cc4)C3)CC2N1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 11/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21382150 1.00 MGLL (0.62) MGLL
SCHEMBL21390269 0.89 MGLL (0.65) MGLL
SCHEMBL21385332 0.89 MGLL (0.65) MGLL
SCHEMBL23211861 0.88 MGLL (0.64) MGLL
SCHEMBL21390556 0.88 MGLL (0.64) MGLL
SCHEMBL23149008 0.86 MGLL (0.65) MGLL
SCHEMBL21390353 0.86 MGLL (0.65) MGLL
SCHEMBL23211724 0.86 MGLL (0.65) MGLL
SCHEMBL25057337 0.86 MGLL (0.65) MGLL
SCHEMBL21390359 0.86 MGLL (0.65) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768684-B1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS HOFFMANN LA ROCHE (CH) 2023-02-22 — — EP disclosed
WO-2019180185-A1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2019-09-26 — — WO disclosed
Send feedback